Increasing prevalence of mental disorders to drive the Electroconvulsive Therapy Devices Market worldwide
Electroconvulsive therapy (ECT) is a safe and highly effective treatment for the management of acute episodes of a variety of serious mental disorders. In simple terms, it is an electronic device designed for inducing a brain seizure to treat a mental disorder. The device is particularly used to treat major depressive episodes that are resistant to multiple interventions with treatment alternatives. ECT devices are proved to be highly effective for the relief of major depression.
ECT is considered most safe and effective for certain psychiatric disorders. It is used with informed consent in treatment-resistant major depressive disorder, catatonia, or prolonged or severe mania. It is widely preferred in conditions where there is a need for rapid, definitive response because of the severity of a medical condition. For instance, when severity is characterized by stupor, marked psychomotor retardation, depressive delusions or hallucinations, or life-threatening physical exhaustion associated with mania.
Increasing cases of mental illness due to heavy brain injuries; changing lifestyle and increasing exposure to harmful toxins; and advances in technology and widely used by developed nations such as America, Canada, Germany, Austria and Denmark influences emerging nations for the use of Electroconvulsive therapy (ECT) device. These are certainly major factors driving the growth of the market. Increasing consumption of tobacco gives rise to bacterial infection causing mental instability, is one key trend expected to boost the market growth in the coming years.
The market is segmented into Hospitals, Specialty Clinics, Mental Hospitals, and Others. Among these, the mental hospitals dominated the largest market share owing to increasing number of patients for severe mental disorders across the globe.
Treatment for severe depression to rise the Electroconvulsive Therapy market in the North America region
North America holds the largest market share followed by Europe, and the Asia Pacific. The growth in North America is widely attributed to the adoption of Electroconvulsive Therapy in the U.S. In the United States, an estimated 100,000 Americans receives the treatment annually, most of them women. Rising awareness for the treatment for severe depression owing to the high prevalence of mental disorders, and other harmful diseases such as schizophrenia, catatonia among others is a key driver attributed for the growth of the market in this region.
According to W.H.O., there are over 350 million people in world who suffer from depression and the depression treatment market has a huge potential to grow. The prevalence rates are very high in the Asia Pacific and African regions ranging from 4 to 7%. As per the estimates by W.H.O. depression will soon replace heart disease as the heaviest disease burden on countries.